Status:

TERMINATED

Cannabidiol - an in Vivo Innovative Drug Delivery Study

Lead Sponsor:

Central Institute of Mental Health, Mannheim

Conditions:

Pharmacokinetics, Bioavailability

Eligibility:

All Genders

18-85 years

Phase:

PHASE1

Brief Summary

Basic characterization of the drug delivery system for cannabidiol. A comparative bioavailability study.

Detailed Description

This study aims to investigate an innovative pharmaceutical preparation of cannabidiol. Thus, a comparative bioavailability study will be conducted, comparing cannabidiol capsules (reference formulati...

Eligibility Criteria

Inclusion

  • Informed consent given by the subject
  • Negative drug screening at the time of screening
  • Non-smoking
  • In female participants in fertile age, reliable contraception, which means contraception's Pearl index is equal to or smaller than 1.
  • Body Mass Index between 18.5 kg/m2 and 30 kg/m2

Exclusion

  • Lack of accountability
  • Pregnancy or lactation phase in females at the time of screening
  • Any known psychiatric or neurological illness in the participant's history.
  • Known family history regarding psychiatric disorders with an increased lifetime risk for psychiatric disorders in the participant (investigators qualified judgement)
  • Relevant use of cannabis (which is defined on the present state of knowledge as more than five times lifetime consumption and/or more than two consumptions during the last year)
  • Consumption of any illicit drugs (except cannabis in history, see above)
  • Severe physical (internal) or neurological illness, especially cardiovascular, renal, advanced respiratory, haematologic or endocrinologic disorders or infectious diseases (acute hepatitis A, B or C or HIV) assessed at the time of the screening by the subject's history, clinical examination and laboratory testing, as assessed by the investigator

Key Trial Info

Start Date :

December 10 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 29 2019

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT03471559

Start Date

December 10 2018

End Date

August 29 2019

Last Update

July 1 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department I of Pharmacology, University of Cologne

Cologne, Germany, 50931

Cannabidiol - an in Vivo Innovative Drug Delivery Study | DecenTrialz